12/20
02:03 am
amrn
Amarin Co. plc (NASDAQ: AMRN) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Low
Report
Amarin Co. plc (NASDAQ: AMRN) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
12/16
07:10 am
amrn
Amarin Receives National Reimbursement for VAZKEPA® in Italy [Yahoo! Finance]
Medium
Report
Amarin Receives National Reimbursement for VAZKEPA® in Italy [Yahoo! Finance]
12/16
07:00 am
amrn
Amarin Receives National Reimbursement for VAZKEPA® in Italy
Low
Report
Amarin Receives National Reimbursement for VAZKEPA® in Italy
12/13
09:14 am
amrn
Amarin Appoints Peter Fishman Chief Financial Officer [Yahoo! Finance]
Low
Report
Amarin Appoints Peter Fishman Chief Financial Officer [Yahoo! Finance]
12/13
09:00 am
amrn
Amarin Appoints Peter Fishman Chief Financial Officer
Medium
Report
Amarin Appoints Peter Fishman Chief Financial Officer
12/12
02:03 am
amrn
Amarin Co. plc (NASDAQ: AMRN) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Low
Report
Amarin Co. plc (NASDAQ: AMRN) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
12/4
02:08 am
amrn
Amarin Co. plc (NASDAQ: AMRN) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Low
Report
Amarin Co. plc (NASDAQ: AMRN) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
11/27
12:02 am
amrn
Amarin Co. plc (NASDAQ: AMRN) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Medium
Report
Amarin Co. plc (NASDAQ: AMRN) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
11/19
10:51 am
amrn
After Plunging -19.13% in 4 Weeks, Here's Why the Trend Might Reverse for Amarin (AMRN) [Yahoo! Finance]
Low
Report
After Plunging -19.13% in 4 Weeks, Here's Why the Trend Might Reverse for Amarin (AMRN) [Yahoo! Finance]
11/11
08:00 am
amrn
Investigators to Present New REDUCE-IT Subanalysis of VASCEPA®/VAZKEPA® (icosapent ethyl) in Patients With and Without Coronary Artery Disease History and Mechanistic Data on Eicosapentaenoic Acid (EPA) at the American Heart Association’s (AHA) Annual Sci
Medium
Report
Investigators to Present New REDUCE-IT Subanalysis of VASCEPA®/VAZKEPA® (icosapent ethyl) in Patients With and Without Coronary Artery Disease History and Mechanistic Data on Eicosapentaenoic Acid (EPA) at the American Heart Association’s (AHA) Annual Sci
10/30
04:05 pm
amrn
Amarin Reports Third Quarter 2024 Financial Results and Provides Business Update
Low
Report
Amarin Reports Third Quarter 2024 Financial Results and Provides Business Update
10/1
08:00 am
amrn
Amarin Announces Two Upcoming Investor Events
Medium
Report
Amarin Announces Two Upcoming Investor Events